Covering Global Pharmaceutical Regulations in a Quality System
This article describes how to address compliance with a wide range of applicable regulations within a company’s quality system. The focus is on the way regulatory intelligence can be obtained and subsequently be interpreted within the quality system. Roles and responsibilities of those involved are also discussed.
Regulatory agencies try to harmonise regulations regionally and to some extent globally, but that still requires a lot of work. To remain up-to-date with the Good Practices, i.e. remain in a continued state of compliance, one needs to be aware of the regulations, interpret their impact on the quality system and operations, and if necessary, then change, adapt and improve these. This process is a continuous improvement process cycle in Pharmaceutical Industries (1).
2. US FDA. CFR - Code of Federal Regulations Title 21 [Internet]. US FDA; 2018 Apr. 09 [cited 2018 Jun 12]. Available from:
3. US FDA. CFR - Code of Federal Regulations Title 21 [Internet]. US FDA; 2018 Apr. 09 [cited 2018 Jun 12]. Available from:
4. ICH. Quality Risk Management Q9 [Internet]. ICH; 2005 Nov. 09 [cited 2018 Jun 17]. Available from:
5. Badjatya J, Bodla R. Harmonization & advancement in Pharmaceutical industry. International Journal of Drug Regulatory Affairs [Internet]. 2018 Feb. 06 [cited 2018 Sep 12]; 1(2):7-10. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM